Searched for
OZEMPIC ECONOMY
Harsh Goenka 2027 predictions: Trump, AI bubble fears, inflation, climate risks and 10 predictions about the year aheadIndustrialist Harsh Goenka has identified 10 developments to watch in 2027, including the political transition in the US, Iran-related geop...
From hunger to obesity: Developing world faces growing threat to child healthChildhood obesity is rapidly increasing in developing nations, creating a significant health challenge. This epidemic is now outpacing unde...
Drug regulator transfers 95 officials in mass reshuffleThe Central Drugs Standard Control Organisation has moved about 95 officials across India. This reshuffle aims to improve compliance and le...
Endurance, the new superpower of the battlefieldThe economy of attrition is the big new reality of the battlefield. Expensive defences are badly struggling against waves of cheap drones a...
As Ozempic's active ingredient's patent expires today, India's fit for a health-lifestyle revolutionNovo Nordisk's India patent expiry today unlocks affordable semaglutide, set to transform diabetes and weight management. Local players are...
Bharat Biotech bets on vaccines to fight drug resistance, eyes post-Covid growthHyderabad-based Bharat Biotech is developing novel vaccines to combat antimicrobial resistance (AMR), a significant global health threat. T...
Novo Nordisk bets on cheaper Ozempic to dominate India’s booming weight-loss marketNovo Nordisk has launched Ozempic in India at a competitive price, aiming to capture a significant share of the growing weight-loss market....
If Nuclear war broke out tomorrow, which U.S. cities would be destroyed first?Experts and defense analysts identify U.S. cities most vulnerable in a nuclear conflict. Washington D.C., New York City, and Los Angeles ar...
US stock market today: Nasdaq dropped 1.9%, S&P 500 lost 1.1%, Dow slipped 0.8% — What led to Wall Street turning red and why Tesla, Nvidia, Amazon, and Palantir sankUS stock market fell hard today as AI hype cracked. The Nasdaq plunged 1.9%, the S&P 500 slipped 1.1%, and the Dow lost 0.8%. Tesla slid 3....
US stock market rebounded sharply today: What is fuelling Dow, S&P, and Nasdaq rise? AMD, Seagate, Micron, and Western Digital hit record highsU.S. stock market rebounded Wednesday as investors brushed off AI bubble fears and the Supreme Court questioned Trump’s tariff authority. T...
US stocks Dow, S&P 500, and Nasdaq move uneasily as Trump calms China trade fears, banks start to recoverUS stocks turned higher after President Trump said high tariffs on China will not stay. This helped markets recover from earlier losses cau...
S&P, Nasdaq hit record highs as Fed signals more easing; Intel, Nvidia surgeWall Street is nearing record highs, driven by a tech stock surge. Nvidia and Intel's $5 billion partnership boosts the market. Economic re...
Biocon drops plan to launch weight-loss drugs in China, executive saysBiocon has scrapped its plans to introduce generic versions of Novo Nordisk's Ozempic and Wegovy in China, citing intense local competition...
Trump’s $1.4 trillion tariff threat spurs companies to seek coverCompanies like Novo Nordisk, Boeing, and Walmart are preparing for the impacts of President Donald Trump’s tariffs. Executives are assessin...
US' credit score hangover hitting riskiest borrowers. Are there more troubles ahead?Credit scores in United States of America soared during the pandemic, enabling a borrowing binge that has now forced a reckoning. Even for ...
What can a wonder drug maker and a phone maker have in common? Their fall from graceNovo Nordisk's reign as Europe's most valuable company is facing a challenge from US rival Eli Lilly. Lilly's weight-loss drug, Zepbound, i...
Biocon seeks partner to test generic Wegovy, Ozempic in ChinaIndia's Biocon is seeking a Chinese partner to conduct clinical trials on generic versions of Novo Nordisk's popular diabetes drug Ozempic ...
Ozempic: Bengaluru is the secret ingredient behind the wonder weight loss drugs' successNovo Nordisk's India team played a pivotal role in the success of Ozempic, a semaglutide-based drug for diabetes and weight management. The...
US stock market: Wall Street advances as bond yields fall, investors digest Fed minutesTrading was choppy on Wednesday with all the indexes starting off the session with gains before turning lower ahead of the minutes and then...
Weight-loss drug Wegovy launches in the UK as Novo Nordisk shares reach new heights amid supply challengesThe Danish pharmaceutical company Novo Nordisk has introduced its weight-loss drug Wegovy to the United Kingdom. This strategic expansion i...